[
  {
    "criterion": "Does not consider the patient's history of urinary retention when assessing the potential impact of Donepezil on the patient's symptoms.",
    "axis": "completeness",
    "point": -5
  },
  {
    "criterion": "States that Donepezil is contraindicated for patients with benign prostatic hyperplasia.",
    "axis": "accuracy",
    "point": -8
  },
  {
    "criterion": "Asks for more information about the patient's symptoms or medical history to better understand the context.",
    "axis": "context_awareness",
    "point": 5
  },
  {
    "criterion": "Provides a clear and concise explanation of the potential impact of Donepezil on the patient's urinary retention.",
    "axis": "communication_quality",
    "point": 8
  },
  {
    "criterion": "Follows the doctor's instructions to clarify the patient's treatment plan.",
    "axis": "instruction_following",
    "point": 5
  },
  {
    "criterion": "Does not consider the patient's age or other potential factors that may affect the medication's efficacy or side effects.",
    "axis": "completeness",
    "point": -3
  },
  {
    "criterion": "States that the patient should stop taking Donepezil immediately if they experience urinary retention.",
    "axis": "accuracy",
    "point": -9
  },
  {
    "criterion": "Advises the doctor to consult with a specialist or conduct further research before making a decision about the patient's treatment plan.",
    "axis": "context_awareness",
    "point": 3
  },
  {
    "criterion": "Provides a detailed explanation of the potential benefits and risks of adjusting the patient's treatment plan.",
    "axis": "communication_quality",
    "point": 9
  }
]